title: Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure.
abstract: BACKGROUND
  Multiple organ dysfunction syndrome (MODS) observed in patients with sepsis and in nonseptic patients organ failure (OF) is associated with a high mortality rate. We investigated whether new coagulation assays [quantification of procoagulant phospholipids (PPL) activity, functional assays measuring the activity of thrombomodulin (TMa) or tissue factor (TFa) and thrombin generation using calibrated automated thrombography (CAT)] could constitute new tools to better understand the physiopathology of MODS and have any prognostic value.
  
  
  METHODS
  We measured TMa, TFa, PPL and CAT in 32 healthy controls, 24 patients with sepsis and 26 patients with non-septic OF. We compared these parameters with usual coagulation assays [prothrombin time, activated partial thromboplastin time, protein C (PC), protein S, D-Dimers (D-Di), soluble thrombomodulin (sTM)] and markers of inflammation (IL-6, CRP). Samples were collected within 24 h of the diagnosis.
  
  
  RESULTS
  TMa, TFa, PPL, the lag time and time to thrombin peak levels were increased in both groups of patients. For both groups D-Di, IL-6, CRP and endogenous thrombin potential (ETP) were higher in non-survivors than in survivors, while PC and PPL were lower in non-survivors than in survivors. TMa increase was more marked in non-survivors patients with OF, while the ratio TMa/sTM was low in non-survivors with sepsis. Received operating characteristic (ROC) curve analysis indicated that thrombin peak and ETP were the more powerful discriminating factors in patients with sepsis or non-septic OF, respectively.
  
  
  CONCLUSIONS
  PPL, TMa and CAT assays could represent promising tools to identify patients with increased risk of mortality in MODS and could procure insights into pathogenesis of MODS.
authors.affiliation: Diagnostica Stago, Gennevilliers cedex, France.
authors.forename: Patrick
authors.initials: P
authors.lastname: Van Dreden
authors.forename: Barry
authors.initials: B
authors.lastname: Woodhams
authors.forename: Aurélie
authors.initials: A
authors.lastname: Rousseau
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Dreyfus
authors.forename: Marc
authors.initials: M
authors.lastname: Vasse
mesh_terms: D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D015331:Cohort Studies; D003422:Critical Care; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000097:blood*; D010743:Phospholipids / Q000097:blood*; D011379:Prognosis; D018805:Sepsis / Q000097:blood*; D013917:Thrombin / Q000378:metabolism*; D018180:Thrombomodulin / Q000097:blood*
chemical_list: D015415:Biomarkers; D010743:Phospholipids; D018180:Thrombomodulin; D013917:Thrombin